Century Therapeutics, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $109.2 | $6.6 | $2.2 | $5.2 | — |
| Operating income | -$17.3 | -$138.1 | -$146.5 | -$133.8 | -$94.9 |
| Net income | -$9.6 | -$126.6 | -$136.7 | -$130.9 | -$95.8 |
| Balance Sheet | |||||
| Total debt | — | — | — | $10.0 | $10.0 |
| Cash Flow Statement | |||||
| Free cash flow | -$104.7 | -$110.3 | -$102.1 | -$16.6 | -$134.0 |
Shares outstanding 180.4M · Free float 85.3%
Annual filing data through FY ended December 31, 2025; float as of July 16, 2026.